{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:15:21Z","timestamp":1790957721257,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Puberty is a critical process for the development of sexual organs and reproductive ability. It is triggered and regulated by the hormones. Rosuvastatin can delay the onset of puberty through the inhibition of cholesterol and androgen biosynthesis. On the other hand, montelukast has protective effects against various diseases and against reproductive toxicity induced by other medications, but its effects on puberty have not been studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>Assessment of the protective effect of montelukast against rosuvastatin-induced delayed puberty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>At the university.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Eighteen male Wistar rats aged 30 days and weighted 50\u201360 g were distributed to three groups (six rats per group) and intraperitoneally administered every day for 5 days with 0.2 ml of distilled water as control, 10 mg\/kg of rosuvastatin and with rosuvastatin + montelukast (10 mg\/kg for each drug). These animals\u2019 groups were euthanised on day 50 of age to assess the effect of rosuvastatin alone and with montelukast on the serum levels of the reproductive hormones and histological manifestations and morphometric measurements of the testes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>One-way analysis of variance and Bonferroni multiple tests were performed to analyse the findings using the GraphPad Prism software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Treatment of rats with rosuvastatin showed a significantly decreased level of testosterone and luteinising hormone as well as histopathological and morphometric alterations in the testicular tissues in comparison with the control. Interestingly, co-treatment of rosuvastatin with montelukast could not reverse or mitigate these changes induced late puberty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>There is no protective effect of montelukast against rosuvastatin-induced delayed puberty.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_56_22","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T04:40:00Z","timestamp":1664512800000},"page":"228-232","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Investigation of Montelukast Effect on Rosuvastatin Induced Late Puberty in Rats"],"prefix":"10.4103","volume":"15","author":[{"given":"Tamadir Hamid Wadi","family":"Aledani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal Nasser","family":"Al-Hayder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suha Haitham","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawaa Salim","family":"Al-Mayyahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20240905","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.adolescence.2018.12.007","article-title":"Physiology of puberty in boys and girls and pathological disorders affecting its onset","volume":"71","author":"Alotaibi","year":"2019","journal-title":"J Adolesc"},{"key":"R2-4-20240905","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.yfrne.2016.12.003","article-title":"Puberty and structural brain development in humans","volume":"44","author":"Herting","year":"2017","journal-title":"Front Neuroendocrinol"},{"key":"R3-4-20240905","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.3928\/19382359-20190322-01","article-title":"Puberty: Onset and progression","volume":"48","author":"Khan","year":"2019","journal-title":"Pediatr Ann"},{"key":"R4-4-20240905","doi-asserted-by":"crossref","first-page":"101316","DOI":"10.1016\/j.beem.2019.101316","article-title":"Constitutional delay of puberty versus congenital hypogonadotropic hypogonadism: Genetics, management and updates","volume":"33","author":"Raivio","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R6-4-20240905","first-page":"160","article-title":"Use of statins for dyslipidemia in the pediatric population","volume":"15","author":"Eiland","year":"2010","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R7-4-20240905","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.fct.2018.05.043","article-title":"Ascorbic acid co-administered with rosuvastatin reduces reproductive impairment in the male offspring from male rats exposed to the statin at pre-puberty","volume":"118","author":"Leite","year":"2018","journal-title":"Food Chem Toxicol"},{"key":"R8-4-20240905","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3345\/cep.2019.00325","article-title":"Montelukast use over the past 20 years: Monitoring of its effects and safety issues","volume":"63","author":"Lee","year":"2020","journal-title":"Clin Exp Pediatr"},{"key":"R9-4-20240905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/9396425","article-title":"Resveratrol and montelukast alleviate paraquat-induced hepatic injury in mice: Modulation of oxidative stress, inflammation, and apoptosis","volume":"2017","author":"El-Boghdady","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"R10-4-20240905","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.12659\/MSM.912774","article-title":"Effect of montelukast on bronchopulmonary dysplasia (BPD) and related mechanisms","volume":"25","author":"Chen","year":"2019","journal-title":"Med Sci Monit"},{"key":"R11-4-20240905","doi-asserted-by":"crossref","first-page":"106447","DOI":"10.1016\/j.prostaglandins.2020.106447","article-title":"Mechanisms underlying the protective effect of leukotriene receptor antagonist montelukast against doxorubicin induced testicular injury in rats","volume":"149","author":"Mohamed","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"R12-4-20240905","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.fct.2017.09.003","article-title":"Vitamin C partially prevents reproductive damage in adult male rats exposed to rosuvastatin during prepuberty","volume":"109","author":"Leite","year":"2017","journal-title":"Food Chem Toxicol"},{"key":"R13-4-20240905","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/and.12042","article-title":"Effects of montelukast and zileuton on testicular torsion\/detorsion injury in rats","volume":"46","author":"Isikdemir","year":"2014","journal-title":"Andrologia"},{"key":"R14-4-20240905","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/syn.21909","article-title":"Synaptic number changes in the medial prefrontal cortex across adolescence in male and female rats: A role for pubertal onset","volume":"70","author":"Drzewiecki","year":"2016","journal-title":"Synapse"},{"key":"R15-4-20240905","first-page":"624","article-title":"The laboratory rat: Relating its age with Human's","volume":"4","author":"Sengupta","year":"2013","journal-title":"Int J Prev Med"},{"key":"R16-4-20240905","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1590\/S0100-879X2003000700007","article-title":"Reproductive ability of pubertal male and female rats","volume":"36","author":"Zemunik","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"R17-4-20240905","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.reprotox.2014.01.004","article-title":"Delayed reproductive development in pubertal male rats exposed to the hypolipemiant agent rosuvastatin since prepuberty","volume":"44","author":"Leite","year":"2014","journal-title":"Reprod Toxicol"},{"key":"R18-4-20240905","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.crtox.2020.11.002","article-title":"Short- and long-term effects on reproductive parameters of female Wistar rats after exposure to rosuvastatin starting in pre-puberty","volume":"1","author":"Barros","year":"2020","journal-title":"Curr Res Toxicol"},{"key":"R19-4-20240905","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00280-011-1692-y","article-title":"Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats","volume":"69","author":"Beytur","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"R20-4-20240905","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/ddr.21581","article-title":"Montelukast modifies simvastatin-induced myopathy and hepatotoxicity","volume":"80","author":"Hareedy","year":"2019","journal-title":"Drug Dev Res"},{"key":"R21-4-20240905","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/jat.3599","article-title":"Lower sperm quality and testicular and epididymal structural impairment in adult rats exposed to rosuvastatin during prepuberty","volume":"38","author":"Leite","year":"2018","journal-title":"J Appl Toxicol"},{"key":"R22-4-20240905","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1095\/biolreprod64.3.735","article-title":"Negative feedback regulation of the secretion and actions of gonadotropin-releasing hormone in males","volume":"64","author":"Tilbrook","year":"2001","journal-title":"Biol Reprod"},{"key":"R23-4-20240905","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1210\/endo.142.9.8375","article-title":"Caspase-3 and caspase-activated deoxyribonuclease are associated with testicular germ cell apoptosis resulting from reduced intratesticular testosterone","volume":"142","author":"Kim","year":"2001","journal-title":"Endocrinology"},{"key":"R24-4-20240905","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1210\/en.2003-0735","article-title":"Reduced intratesticular testosterone concentration alters the polymerization State of the sertoli cell intermediate filament cytoskeleton by degradation of vimentin","volume":"144","author":"Show","year":"2003","journal-title":"Endocrinology"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_56_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:15:57Z","timestamp":1787757357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_56_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_56_22","relation":{},"ISSN":["0974-1208"],"issn-type":[{"value":"0974-1208","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}